Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact
CONCLUSIONS: Optimization/simplification accounts for almost half of the reasons for TAR change, with an economic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time.PMID:37731312 | DOI:10.37201/req/047.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 21, 2023 Category: Drugs & Pharmacology Authors: E Herranz-Bayo H Navarro-Azn árez A Pinilla-Rello C I D íaz-Calderón-Horcada Source Type: research

Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact
CONCLUSIONS: Optimization/simplification accounts for almost half of the reasons for TAR change, with an economic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time.PMID:37731312 | DOI:10.37201/req/047.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 21, 2023 Category: Drugs & Pharmacology Authors: E Herranz-Bayo H Navarro-Azn árez A Pinilla-Rello C I D íaz-Calderón-Horcada Source Type: research

Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact
CONCLUSIONS: Optimization/simplification accounts for almost half of the reasons for TAR change, with an economic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time.PMID:37731312 | DOI:10.37201/req/047.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 21, 2023 Category: Drugs & Pharmacology Authors: E Herranz-Bayo H Navarro-Azn árez A Pinilla-Rello C I D íaz-Calderón-Horcada Source Type: research

Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact
CONCLUSIONS: Optimization/simplification accounts for almost half of the reasons for TAR change, with an economic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time.PMID:37731312 | DOI:10.37201/req/047.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 21, 2023 Category: Drugs & Pharmacology Authors: E Herranz-Bayo H Navarro-Azn árez A Pinilla-Rello C I D íaz-Calderón-Horcada Source Type: research

Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project
CONCLUSIONS: The pharmaceutical intervention based onarmaceutical intervention based on the CMO methodology significantly decreased the prevalence of the PIMDINAC concept and increased the number of patients who achieved the objectives, optimising their pharmacotherapy.PMID:37724451 | DOI:10.37201/req/021.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 19, 2023 Category: Drugs & Pharmacology Authors: E S ánchez-Yáñez M J Huertas-Fern ández M A Robustillo-Cortes R Ramos-Guerrero S Fern ández-Espínola R Diaz-Acedo V Montero-Martin R Morillo-Verdugo Source Type: research

Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project
CONCLUSIONS: The pharmaceutical intervention based onarmaceutical intervention based on the CMO methodology significantly decreased the prevalence of the PIMDINAC concept and increased the number of patients who achieved the objectives, optimising their pharmacotherapy.PMID:37724451 | DOI:10.37201/req/021.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 19, 2023 Category: Drugs & Pharmacology Authors: E S ánchez-Yáñez M J Huertas-Fern ández M A Robustillo-Cortes R Ramos-Guerrero S Fern ández-Espínola R Diaz-Acedo V Montero-Martin R Morillo-Verdugo Source Type: research

Prevalence of mutations associated with macrolide and fluoroquinolone resistance in Neisseria gonorrhoeae with Allplex NG-DR Assay (Seegene) in a tertiary hospital from Madrid, Spain
CONCLUSIONS: We report a low-prevalence of mutations A2059G/C2611T to macrolides and a high-prevalence to S91F in NG infections. Molecular methods for the detection of NG resistance could be useful in direct non-culturable samples.PMID:37721708 | DOI:10.37201/req/058.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 18, 2023 Category: Drugs & Pharmacology Authors: A Maldonado-Barrueco C Sanz-Gonz ález I Falces-Romero P Garc ía-Clemente J Cacho-Calvo I Quiles-Melero Source Type: research

Prevalence of mutations associated with macrolide and fluoroquinolone resistance in Neisseria gonorrhoeae with Allplex NG-DR Assay (Seegene) in a tertiary hospital from Madrid, Spain
CONCLUSIONS: We report a low-prevalence of mutations A2059G/C2611T to macrolides and a high-prevalence to S91F in NG infections. Molecular methods for the detection of NG resistance could be useful in direct non-culturable samples.PMID:37721708 | DOI:10.37201/req/058.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 18, 2023 Category: Drugs & Pharmacology Authors: A Maldonado-Barrueco C Sanz-Gonz ález I Falces-Romero P Garc ía-Clemente J Cacho-Calvo I Quiles-Melero Source Type: research

Do face masks increase the rate of the Staphylococcus aureus nasal carriers?
Rev Esp Quimioter. 2023 Sep 7:urquia07sep2023. doi: 10.37201/req/082.2023. Online ahead of print.NO ABSTRACTPMID:37675477 | DOI:10.37201/req/082.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 7, 2023 Category: Drugs & Pharmacology Authors: S Urqu ía-Cutillas M L G ómez-Lus D Sevillano N Gonz ález L Alou Source Type: research

Update on Bimervax ® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)
Rev Esp Quimioter. 2023 Sep 8:cambra08sep2023. doi: 10.37201/req/085.2023. Online ahead of print.NO ABSTRACTPMID:37675837 | DOI:10.37201/req/085.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 7, 2023 Category: Drugs & Pharmacology Authors: C Borralleras J Castrodeza Sanz P Arrazola C C ámara Hijón J M Eiros J Castrodeza Sanz P Arrazola C C ámara Hijón M Fern ández-Prada A Gil de Miguel G Mirada Masip F Moraga-Llop D Oca ña Rodríguez J Puig-Barber à J V ázquez J Vergara-Alert S de C Source Type: research

Do face masks increase the rate of the Staphylococcus aureus nasal carriers?
Rev Esp Quimioter. 2023 Sep 7:urquia07sep2023. doi: 10.37201/req/082.2023. Online ahead of print.NO ABSTRACTPMID:37675477 | DOI:10.37201/req/082.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 7, 2023 Category: Drugs & Pharmacology Authors: S Urqu ía-Cutillas M L G ómez-Lus D Sevillano N Gonz ález L Alou Source Type: research

Update on Bimervax ® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)
Rev Esp Quimioter. 2023 Sep 8:cambra08sep2023. doi: 10.37201/req/085.2023. Online ahead of print.NO ABSTRACTPMID:37675837 | DOI:10.37201/req/085.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 7, 2023 Category: Drugs & Pharmacology Authors: C Borralleras J Castrodeza Sanz P Arrazola C C ámara Hijón J M Eiros J Castrodeza Sanz P Arrazola C C ámara Hijón M Fern ández-Prada A Gil de Miguel G Mirada Masip F Moraga-Llop D Oca ña Rodríguez J Puig-Barber à J V ázquez J Vergara-Alert S de C Source Type: research

Do face masks increase the rate of the Staphylococcus aureus nasal carriers?
Rev Esp Quimioter. 2023 Sep 7:urquia07sep2023. doi: 10.37201/req/082.2023. Online ahead of print.NO ABSTRACTPMID:37675477 | DOI:10.37201/req/082.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 7, 2023 Category: Drugs & Pharmacology Authors: S Urqu ía-Cutillas M L G ómez-Lus D Sevillano N Gonz ález L Alou Source Type: research

Update on Bimervax ® immunogenicity amplitude. Insights on humoral response against XBB.1.5 from an extension study (NTC05142553)
Rev Esp Quimioter. 2023 Sep 8:cambra08sep2023. doi: 10.37201/req/085.2023. Online ahead of print.NO ABSTRACTPMID:37675837 | DOI:10.37201/req/085.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 7, 2023 Category: Drugs & Pharmacology Authors: C Borralleras J Castrodeza Sanz P Arrazola C C ámara Hijón J M Eiros J Castrodeza Sanz P Arrazola C C ámara Hijón M Fern ández-Prada A Gil de Miguel G Mirada Masip F Moraga-Llop D Oca ña Rodríguez J Puig-Barber à J V ázquez J Vergara-Alert S de C Source Type: research

Do face masks increase the rate of the Staphylococcus aureus nasal carriers?
Rev Esp Quimioter. 2023 Sep 7:urquia07sep2023. doi: 10.37201/req/082.2023. Online ahead of print.NO ABSTRACTPMID:37675477 | DOI:10.37201/req/082.2023 (Source: Revista Espanola de Quimioterapia)
Source: Revista Espanola de Quimioterapia - September 7, 2023 Category: Drugs & Pharmacology Authors: S Urqu ía-Cutillas M L G ómez-Lus D Sevillano N Gonz ález L Alou Source Type: research